SEC Form D · filed July 12, 2021
ADIAL PHARMACEUTICALS, INC
Location
CHARLOTTESVILLE, VA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
William B. Stilley, Iii · Charlottesville, VAExec · DirectorJames W. Newman, Jr · Charlottesville, VADirectorKevin W. Schuyler · Charlottesville, VADirectorJames K. Anderson · Charlottesville, VADirectorTony W. Goodman · Charlottesville, VADirectorJoseph M. Truluck · Charlottesville, VAExecRobertson H. Gilliland · Charlottesville, VADirectorKweli Washington · New York, NYDirectorPeter Feld · New York, NYDirectorMichael Korn · New York, NYDirectorW. C. Mccollum · Los Angeles, CAExecGina Mondo · Norwich, CTExec · DirectorMike Kerns · Playa Vista, CADirectorJesse S. Jacobs · Playa Vista, CADirectorThomas Scriven · Golden, CODirectorMatthew Davis · Purcellville, VADirectorFred Ausubel · Allston, MAExecIsaac Stoner · Allston, MAExec · DirectorCory Brown · Nashville, TNDirectorKiran N. Bhatraju · Shepherdstown, WVDirectorElvin Lopez · Whippany, NJDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗